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Abstract Cytochrome c553 is the electron transfer partner of
formate dehydrogenase and of [Fe]-hydrogenase, two metalloen-
zymes essential in the metabolism of sulfate reducing bacteria.
These two enzymes contain a ‘ferredoxin-like’ domain which
presents 30% identity with Desulfovibrio desulfuricans Norway
ferredoxin I. This was chosen as a model for the ‘ferredoxin-like’
domain involved in the electron transfer reaction with cyto-
chrome c553. 1D NMR titration of complex formation gave us
the stoichiometry (1:1) and the dissociation constant of the
complex (Kd V3U1036 M). 2D heteronuclear NMR experi-
ments were performed to analyze the 1H and 15N chemical shift
variations that are induced by the protein-protein recognition.
This is the first mapping of the interaction site on a c-type
cytochrome, using heteronuclear NMR.
z 1999 Federation of European Biochemical Societies.
Key words: Cytochrome c553 ; Ferredoxin;
1H and 15N NMR; Protein-protein interaction
1. Introduction
Sulfate reducing bacteria are anaerobic organisms able to
reduce sulfate, sul¢te or thiosulfate to sul¢de. For growth,
these bacteria use a number of substrates such as lactate,
formate, hydrogen, ethanol, pyruvate, fumarate or malate.
The electron carriers associated with this anaerobic metabo-
lism have been extensively studied from the primary dehydro-
genase, such as lactate or formate dehydrogenase, to the ter-
minal electron acceptor, sul¢te or sulfate reductase. The
electron transfer chains associated with these reactions are
characterized by the presence of low oxidoreduction potential
cytochromes. The monohemic cytochrome c553 is similar to
mitochondrial and photosynthetic cytochromes. The two axial
ligands are methionine and histidine residues as generally
found in the monohemic cytochromes c. However, the oxido-
reduction potential is surprisingly low (40 mV). We are cur-
rently examining structural features of this molecule impor-
tant in determining its reduction potential, and we have
demonstrated that the low oxidoreduction potential of this
cytochrome is correlated with the high exposure of the heme
to the solvent [1]. The electron exchange of this molecule has
been studied with two oxidoreduction partners, formate dehy-
drogenase [2] and [Fe]-hydrogenase [3].
Desulfovibrio desulfuricans Norway (DdN) ferredoxin I
presents 60% homology and 30% identity with the ‘ferredox-
in-like’ domain of Desulfovibrio vulgaris Hildenborough
(DvH) [Fe]-hydrogenase and 27% identity with the N-terminal
sequence of Escherichia coli formate dehydrogenase L subunit.
Kinetic measurements have established that DdN ferredoxin I
reduces DvH cytochrome c553 in the presence of pyruvate de-
hydrogenase and pyruvate [4]. For these reasons, we chose
DdN ferredoxin I as a model for the ‘ferredoxin-like’ domain
of the two enzymes in order to study the general features of
the protein recognition. We have applied a diversi¢ed ap-
proach using 1D and 2D heteronuclear NMR to map the
interacting site on the cytochrome c553.
2. Material and methods
2.1. Protein puri¢cation
Ferredoxin I was puri¢ed from DdN as previously reported [5].
DvH cytochrome c553 was expressed and puri¢ed from Desulfovibrio
desulfuricans G200 as previously described [6]. The 15N labeling of
cytochrome c553 was obtained from 3 l of recombinant D. desulfur-
icans G200 (pRC41) grown on Postgate C medium where yeast extract
was replaced by 15N-Celtone powder [7].
2.2. NMR samples
For heteronuclear NMR experiments the labeled cytochrome c553
was concentrated to 0.1 mM, in potassium phosphate bu¡er 30 mM,
pH 5.9, 10% D2O. Ferredoxin was concentrated to 10 mM in 30 mM
phosphate bu¡er pH 5.9, on an Amicon microconcentrator (Centri-
con). In these conditions the two proteins are at the pH previously
used for proton assignment of cytochrome c553. Titration of complex
formation was obtained by addition of a ferredoxin aliquot to the
cytochrome sample.
2.3. NMR spectra
NMR spectra were recorded on a Bruker Avance DRX 500 spec-
trometer at 296 K. The NMR spectra were processed with UXNMR
and Aurelia software provided by Bruker. 1D NMR spectra were
obtained with a water line presaturation during the relaxation delay.
2D 1H-15N HSQC spectra were recorded using a watergate pulse
sequence in the TPPI mode. The spectral widths are 10 000 Hz for
1H and 2534 Hz for 15N. 2048 data points in t2 and 32 transients for
each 256 t1 were used. 1H chemical shifts were referenced to the H2O
resonance calibrated at 4.792 ppm at 296 K, relative to the sodium
trimethylsilyl-2,2,3,3-(2H4) propionate. 15N chemical shifts were refer-
enced indirectly using the above 1H reference and the gyromagnetic
ratio (0.101329118) [8]. The 1H and 15N chemical shifts of oxidized
cytochrome c553 previously reported [7,9] were used for the resonance
assignments in 1D and 2D experiments.
2.4. Chemical shift analysis
Parameters of complex formation were determined by calculating
the relative induced shifts (vNij/vNit, where vNij is the induced chemical
shift variation and vNit is the maximal induced chemical shift varia-
tion) as a function of the cytochrome c553/ferredoxin ratio. Chemical
shift variations obtained from 1D experiments were deduced from two
di¡erent sets of data with 0.15 mM ferredoxin and 0.5, 0.75, 1, 1.25,
1.5, 1.75, 2 and 3 equivalents of cytochrome. Chemical shift variations
observed in 2D heteronuclear experiments were obtained from a single
set of experiments at 0.1 mM cytochrome c553 concentration and 0.5,
1 and 2 equivalents of ferredoxin.
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3. Results
3.1. 1D NMR analysis of the complex formation
The heme methyl lines of DvH cytochrome c553 are partic-
ularly well resolved and were previously assigned at 296 K
(Me1, 20.69 ppm; Me3, 23.40 ppm; Me5, 22.11 ppm and
Me8, 30.70 ppm) [9]. The resonances of the cysteines bonded
to the [4Fe-4S] cluster of DdN ferredoxin I were also previ-
ously assigned (C9L1, 11.25 ppm; C12L2, 16.87 ppm; C15L1,
16.08 ppm and C51L2, 11.69 ppm) [10]. Any changes to these
proton environments induce chemical shift variations in the
1D NMR spectra.
Fig. 1 shows the 1D NMR titration of the complex forma-
tion. Addition of cytochrome c553 to ferredoxin I provides
proton chemical shift variations. The LCH2 of C12 is partic-
ularly a¡ected by complex formation (vN 0.55 ppm). The res-
onance corresponding to Me5 of the cytochrome is highly
a¡ected (vN 1.51 ppm). Calculating the titration curve plotted
from the chemical shift variations of the ferredoxin C12L, one
can obtain the stoichiometry (1:1) and the dissociation con-
stant (Kd V3U1036 M) of the complex. It is necessary to
keep in mind that the concentrations used in these experi-
ments (0.15 mM) are too high to determine lower values.
3.2. 2D NMR titration of the complex formation
In the 1H-15N HSQC experiment the correlation peaks of
Fig. 1. 1D NMR titration of ferredoxin-cytochrome c553 complex formation. The experiment was performed on a Bruker DRX 500 spectrome-
ter using a ferredoxin solution at 0.15 mM concentration and various concentrations of cytochrome in a 30 mM phosphate bu¡er pH 5.9 at
296 K. Only the 31^10 ppm part of the spectra, containing the protons of the cytochrome c553 heme (Me1, 3, 5 and 8 and propionate 7), the
protons of the ¢fth heme axial ligand H14 and the L protons of the four cysteine ligands of the ferredoxin (4Fe-4S) cluster, are shown.
Fig. 2. 1H and 15N chemical shift variations observed on the NH groups of cytochrome c553 in 2D NMR experiments in the presence of two
excesses of ferredoxin. Stars label non-assigned residues (1, 2, 12, 13, 19, 20, 23, 28, 52 and 58) and non-observable residues in the complex (7,
30, 37 and 53).
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tural variation observed when compared with other c-type
cytochromes concerns the propionate 6 solvent accessibility.
In cytochrome c553, this group is directly exposed to the sol-
vent, a feature unique among cytochromes c. Moreover, the
homonuclear experiment (data not shown) evidenced that the
lateral chain (CKH) of R53 as well as the loop between resi-
dues 20 and 30 are found in the interaction site. The involve-
ment of these two arms of the heme crevice is probably related
to the structural characteristics found for this cytochrome [1].
The encounter surface described for the cytochrome c553-
ferredoxin I complex is in complete agreement with the char-
acteristics of the formate dehydrogenase-cytochrome c553
complex [15]. We have previously reported that the electro-
static interactions are probably the driving force in the com-
plex formation and that K62 and K63 substitution gives a
drastic decrease in the a⁄nity constant. In the present map-
ping both residues are found in the interacting site. Formate
dehydrogenase (Mr 120 kDa) and Fe-hydrogenase (Mr 60
kDa) are large multimeric enzymes, and new insights into
structural NMR give the opportunity to study large proteins
involved in complexes. Therefore, transverse relaxation-opti-
mized spectroscopy experiments [16,17] on these high molec-
ular weight electron transfer complexes should con¢rm the
accuracy of the present model. This approach may be largely
developed for other electron transfer complexes such as cyto-
chrome c/cytochrome c oxidase, cytochrome c/complex bc1,
etc. However, few cytochromes c have been successfully la-
belled [18^21]. Cytochrome c overexpression and labelling is a
special challenge, mainly for mammalian cytochromes. This is
a serious limitation for the study of such oxidoreduction com-
plexes which have not yet been cocrystallized and for which
thermodynamic parameters can only be interpreted through
molecular models.
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